These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 34873285)
1. Antibiotics in critically ill children-a narrative review on different aspects of a rational approach. Bruns N; Dohna-Schwake C Pediatr Res; 2022 Jan; 91(2):440-446. PubMed ID: 34873285 [TBL] [Abstract][Full Text] [Related]
2. Optimal and responsible use of antibiotics. Depuydt P; De Waele JJ Curr Opin Crit Care; 2019 Oct; 25(5):458-464. PubMed ID: 31369410 [TBL] [Abstract][Full Text] [Related]
3. Antibiotic stewardship in sepsis management: toward a balanced use of antibiotics for the severely ill patient. De Waele JJ; Dhaese S Expert Rev Anti Infect Ther; 2019 Feb; 17(2):89-97. PubMed ID: 30672354 [TBL] [Abstract][Full Text] [Related]
4. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis. Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic therapy in sepsis: No next time for a second chance! Shahrami B; Sharif M; Sefidani Forough A; Najmeddin F; Arabzadeh AA; Mojtahedzadeh M J Clin Pharm Ther; 2021 Aug; 46(4):872-876. PubMed ID: 33710622 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use. Rhee C; Kadri SS; Dekker JP; Danner RL; Chen HC; Fram D; Zhang F; Wang R; Klompas M; JAMA Netw Open; 2020 Apr; 3(4):e202899. PubMed ID: 32297949 [TBL] [Abstract][Full Text] [Related]
7. Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Bassetti M; De Waele JJ; Eggimann P; Garnacho-Montero J; Kahlmeter G; Menichetti F; Nicolau DP; Paiva JA; Tumbarello M; Welte T; Wilcox M; Zahar JR; Poulakou G Intensive Care Med; 2015 May; 41(5):776-95. PubMed ID: 25792203 [TBL] [Abstract][Full Text] [Related]
8. Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock. Landersdorfer CB; Nation RL Clin Pharmacol Ther; 2021 Apr; 109(4):892-904. PubMed ID: 33570163 [TBL] [Abstract][Full Text] [Related]
9. Timing and Spectrum of Antibiotic Treatment for Suspected Sepsis and Septic Shock: Why so Controversial? Pak TR; Rhee C; Klompas M Infect Dis Clin North Am; 2022 Dec; 36(4):719-733. PubMed ID: 36328632 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial Treatment Duration in Sepsis and Serious Infections. Busch LM; Kadri SS J Infect Dis; 2020 Jul; 222(Suppl 2):S142-S155. PubMed ID: 32691838 [TBL] [Abstract][Full Text] [Related]
11. An empiric antibiotic protocol using risk stratification improves antibiotic selection and timing in critically ill children. Karsies TJ; Sargel CL; Marquardt DJ; Khan N; Hall MW Ann Am Thorac Soc; 2014 Dec; 11(10):1569-75. PubMed ID: 25402656 [TBL] [Abstract][Full Text] [Related]
12. The use and risks of antibiotics in critically ill patients. Denny KJ; Cotta MO; Parker SL; Roberts JA; Lipman J Expert Opin Drug Saf; 2016 May; 15(5):667-78. PubMed ID: 26961691 [TBL] [Abstract][Full Text] [Related]
13. Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance. Strich JR; Heil EL; Masur H J Infect Dis; 2020 Jul; 222(Suppl 2):S119-S131. PubMed ID: 32691833 [TBL] [Abstract][Full Text] [Related]
14. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation. Campion M; Scully G J Intensive Care Med; 2018 Dec; 33(12):647-655. PubMed ID: 29534630 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523 [TBL] [Abstract][Full Text] [Related]
16. A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill Patients. Carlier M; Roberts JA; Stove V; Verstraete AG; Lipman J; De Waele JJ Antimicrob Agents Chemother; 2015 Aug; 59(8):4689-94. PubMed ID: 26014946 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and appropriateness of novel antibiotics in response to antimicrobial-resistant gram-negative bacteria in patients with sepsis in the ICU. Garduno A; Martín-Loeches I Expert Rev Anti Infect Ther; 2022 Apr; 20(4):513-531. PubMed ID: 34727820 [TBL] [Abstract][Full Text] [Related]
18. Sepsis and the Microbiome: A Vicious Cycle. Miller WD; Keskey R; Alverdy JC J Infect Dis; 2021 Jun; 223(12 Suppl 2):S264-S269. PubMed ID: 33330900 [TBL] [Abstract][Full Text] [Related]
19. How Antibiotics Stewardship Can Be Safely Implemented in Patients with Septic Shock? de Montmollin E; Timsit JF Semin Respir Crit Care Med; 2021 Oct; 42(5):689-697. PubMed ID: 34544186 [TBL] [Abstract][Full Text] [Related]